COLUMBIA LABORATORIES INC (CBRX)

Overview Price 0.66 Price Change Today +$0.02 (+3.13%) P&P rating Zacks Rank N/A - N/A Open Price $0.64 Previous Close $0.64 Daily Range $0.63 - $0.67 52-Week Range $0.61 - $3.65 Volume 201,413 Columbia Laboratories is in the business of developing, manufacturing and selling pharmaceutical products that utilize their proprietary bioadhesive drug delivery technologies to treat various medical conditions. Their focus is developing drugs that improve treatment options for women's health, an area where they have a rich heritage and proven capabilities. Their strategy is to fund development through proof-of-concept, then partner for later-stage clinical trials and commercialization. Other Resources for CBRX Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary Zacks Blog: FDA Issues CRL for Watson's Drug March 1, 2012 Zacks Blog: Update on Watson's Candidate February 15, 2012 Zacks Blog: Watson's Drug Fails to Get Support January 23, 2012 Zacks Blog: Zacks #1 Rank Additions for Friday September 16, 2011 Zacks Blog: Watson to Market Antares' OAB Drug July 12, 2011   No brokerage coverage for CBRX No Data Available

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 3 Buy 0 Sell   Top Buy Analysis BUY: CBRX Company: COLUMBIA LABORATORIES INC. Points: -81.81 Start Price: $2.46 Start Date: 10/01/2011 5:49 PM TomBarrett007 P&P Score: 1.23 Recs: With FDA approval in Feb, this is going to tripple! Comments: 0 | Comment More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
JoeJustJoe	99.94	03/10/12	The 3J market guage remains extreeemely bearish	68	03/13/12
globlchrtanlysis	98.70	12/06/10	CBRX Trade Follow Up 48% Move In 1 Week	0
globlchrtanlysis	98.70	11/30/10	Explosive Low Priced Stocks Report(CBRX,ANO,CMLS,SFI,WRLS,CRWN,JSDA)	0
Zacks_Analysts	0.00	03/01/12	FDA Issues CRL for Watson's Drug - Analyst Blog	0
Zacks_Analysts	0.00	02/15/12	Update on Watson's Candidate - Analyst Blog	0
Zacks_Analysts	0.00	01/23/12	Watson's Drug Fails to Get Support - Analyst Blog	0
Zacks_Analysts	0.00	07/12/11	Watson to Market Antares' OAB Drug - Analyst Blog	0
Zacks_Analysts	0.00	06/29/11	Watson-Columbia Drug's NDA Accepted - Analyst Blog	0
Zacks_Analysts	0.00	04/27/11	Watson Beats on EPS; Ups Guidance - Analyst Blog	0
Zacks_Analysts	0.00	12/07/10	Watson's Prochieve Achieves Target - Analyst Blog	0

Commentary

BUY: COLUMBIA LABORATORIES INC. (CBRX) Start Price: $2.46 Points: -81.81 Created: 10/01/2011 With FDA approval in Feb, this is going to tripple! Comments: 0 | Comment TomBarrett007 Recs:

BUY: COLUMBIA LABORATORIES INC. (CBRX) Start Price: $5.11 Points: -76.97 Created: 01/01/2008 Comments: 0 | Comment nabncash Recs:

BUY: COLUMBIA LABORATORIES INC. (CBRX) Start Price: $4.85 Points: -76.29 Created: 01/01/2008 Comments: 0 | Comment Zyberian Recs:

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
TomBarrett007	1.23	BUY	One to Three Months	10/01/2011	$2.46	$0.65 (+2.35%)	-73.47%	+8.34%	-81.81	view close
nabncash	66.16	BUY	Six Months to a Year	01/01/2008	$5.11	$0.65 (+2.35%)	-87.23%	-10.25%	-76.97
Zyberian	15.33	BUY	Six Months to a Year	01/01/2008	$4.85	$0.65 (+2.35%)	-86.54%	-10.25%	-76.29